Cahuitamycins and methods of making and using the same
AssigneeThe Regents of the University of Michigan
InventorsDavid H. Sherman, Fengan Yu, Chuanwu Xi, Jianfeng Wu, Pamela J. Schultz, Ashootosh Tripathi, Sung Ryeol Park
Life of this patent
Estimating the term…
Abstract
Provided herein are biofilm inhibitors obtained from marine microbial derived natural product extracts from Streptomyces gandocaensis, resulting in biofilm inhibitors, cahuitamycins. Also provided are mutant S. gandocaensis, methods of inhibiting biofilm formation, methods of producing, or increasing the production of, cahuitamycins, methods for synthesizing cahuitamycins, and methods of purifying cahuitamycins.
Claims20
A compound having a structure:
- or a pharmaceutically acceptable salt thereof.
A composition comprising (a) a cahuitamycin compound or pharmaceutically acceptable salt thereof and (b) a pharmaceutically acceptable carrier, wherein the cahuitamycin compound has a structure selected from:
A method of producing a cahuitamycin compound comprising
- (a) culturing Streptomyces gandocaensis
- (i) in the presence of streptomycin to select for a mutated ribosomal protein, thereby generating a mutated S. gandocaensis,
- (ii) under conditions wherein the activity of salicylate synthase is inhibited;
- (iii) under conditions wherein the activity of 6-methylsalicylic acid synthase is inhibited;
- (iv) in the presence of 2-hydroxy-5-methylbenzoic acid or 2-hydroxybenzoic acid and the mutant is Streptomyces gandocaensis lacking salicylate synthase activity;
- and
- (b) obtaining the cahuitamycin compound from the culture.
Dependencies are inferred from the claim text.